Report cover image

Global Amikacin Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 193 Pages
SKU # APRC20553250

Description

Summary

According to APO Research, The global Amikacin market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Amikacin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Amikacin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Amikacin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Amikacin is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Amikacin include TNJ Chemical, Tuochukangyuan Pharm., 3B Scientific, Shenglide Biology, Bide Pharm., TargetMol, Pure Chemistry Scientific, OChem and MuseChem, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Amikacin, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Amikacin, also provides the sales of main regions and countries. Of the upcoming market potential for Amikacin, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Amikacin sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Amikacin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Amikacin sales, projected growth trends, production technology, application and end-user industry.

Amikacin Segment by Company

TNJ Chemical
Tuochukangyuan Pharm.
3B Scientific
Shenglide Biology
Bide Pharm.
TargetMol
Pure Chemistry Scientific
OChem
MuseChem
Mucule
Inter Bio Screen
Clearsynth
Biosynth
Angene
Amikacin Segment by Type

98% Purity Type
99% Purity Type
99.8% Purity Type
Others
Amikacin Segment by Application

Amikacin Eye Drops
Amikacin Injection
Others
Amikacin Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amikacin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amikacin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amikacin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Amikacin market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Amikacin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Amikacin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Amikacin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

193 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Amikacin Market Size, 2020 VS 2024 VS 2031
1.3 Global Amikacin Market Size Estimates and Forecasts (2020-2031)
1.4 Global Amikacin Sales Estimates and Forecasts (2020-2031)
1.5 Global Amikacin Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Amikacin Market Dynamics
2.1 Amikacin Industry Trends
2.2 Amikacin Industry Drivers
2.3 Amikacin Industry Opportunities and Challenges
2.4 Amikacin Industry Restraints
3 Amikacin Market by Manufacturers
3.1 Global Amikacin Revenue by Manufacturers (2020-2025)
3.2 Global Amikacin Sales by Manufacturers (2020-2025)
3.3 Global Amikacin Average Sales Price by Manufacturers (2020-2025)
3.4 Global Amikacin Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Amikacin Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Amikacin Manufacturers, Product Type & Application
3.7 Global Amikacin Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Amikacin Market CR5 and HHI
3.8.2 Global Top 5 and 10 Amikacin Players Market Share by Revenue in 2024
3.8.3 2024 Amikacin Tier 1, Tier 2, and Tier 3
4 Amikacin Market by Type
4.1 Amikacin Type Introduction
4.1.1 98% Purity Type
4.1.2 99% Purity Type
4.1.3 99.8% Purity Type
4.1.4 Others
4.2 Global Amikacin Sales by Type
4.2.1 Global Amikacin Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Amikacin Sales by Type (2020-2031)
4.2.3 Global Amikacin Sales Market Share by Type (2020-2031)
4.3 Global Amikacin Revenue by Type
4.3.1 Global Amikacin Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Amikacin Revenue by Type (2020-2031)
4.3.3 Global Amikacin Revenue Market Share by Type (2020-2031)
5 Amikacin Market by Application
5.1 Amikacin Application Introduction
5.1.1 Amikacin Eye Drops
5.1.2 Amikacin Injection
5.1.3 Others
5.2 Global Amikacin Sales by Application
5.2.1 Global Amikacin Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Amikacin Sales by Application (2020-2031)
5.2.3 Global Amikacin Sales Market Share by Application (2020-2031)
5.3 Global Amikacin Revenue by Application
5.3.1 Global Amikacin Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Amikacin Revenue by Application (2020-2031)
5.3.3 Global Amikacin Revenue Market Share by Application (2020-2031)
6 Global Amikacin Sales by Region
6.1 Global Amikacin Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Amikacin Sales by Region (2020-2031)
6.2.1 Global Amikacin Sales by Region (2020-2025)
6.2.2 Global Amikacin Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Amikacin Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Amikacin Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Amikacin Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Amikacin Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Amikacin Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Amikacin Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Amikacin Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Amikacin Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Amikacin Revenue by Region
7.1 Global Amikacin Revenue by Region
7.1.1 Global Amikacin Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Amikacin Revenue by Region (2020-2025)
7.1.3 Global Amikacin Revenue by Region (2026-2031)
7.1.4 Global Amikacin Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Amikacin Revenue (2020-2031)
7.2.2 North America Amikacin Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Amikacin Revenue (2020-2031)
7.3.2 Europe Amikacin Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Amikacin Revenue (2020-2031)
7.4.2 Asia-Pacific Amikacin Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Amikacin Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Amikacin Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 TNJ Chemical
8.1.1 TNJ Chemical Comapny Information
8.1.2 TNJ Chemical Business Overview
8.1.3 TNJ Chemical Amikacin Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 TNJ Chemical Amikacin Product Portfolio
8.1.5 TNJ Chemical Recent Developments
8.2 Tuochukangyuan Pharm.
8.2.1 Tuochukangyuan Pharm. Comapny Information
8.2.2 Tuochukangyuan Pharm. Business Overview
8.2.3 Tuochukangyuan Pharm. Amikacin Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Tuochukangyuan Pharm. Amikacin Product Portfolio
8.2.5 Tuochukangyuan Pharm. Recent Developments
8.3 3B Scientific
8.3.1 3B Scientific Comapny Information
8.3.2 3B Scientific Business Overview
8.3.3 3B Scientific Amikacin Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 3B Scientific Amikacin Product Portfolio
8.3.5 3B Scientific Recent Developments
8.4 Shenglide Biology
8.4.1 Shenglide Biology Comapny Information
8.4.2 Shenglide Biology Business Overview
8.4.3 Shenglide Biology Amikacin Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Shenglide Biology Amikacin Product Portfolio
8.4.5 Shenglide Biology Recent Developments
8.5 Bide Pharm.
8.5.1 Bide Pharm. Comapny Information
8.5.2 Bide Pharm. Business Overview
8.5.3 Bide Pharm. Amikacin Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Bide Pharm. Amikacin Product Portfolio
8.5.5 Bide Pharm. Recent Developments
8.6 TargetMol
8.6.1 TargetMol Comapny Information
8.6.2 TargetMol Business Overview
8.6.3 TargetMol Amikacin Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 TargetMol Amikacin Product Portfolio
8.6.5 TargetMol Recent Developments
8.7 Pure Chemistry Scientific
8.7.1 Pure Chemistry Scientific Comapny Information
8.7.2 Pure Chemistry Scientific Business Overview
8.7.3 Pure Chemistry Scientific Amikacin Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Pure Chemistry Scientific Amikacin Product Portfolio
8.7.5 Pure Chemistry Scientific Recent Developments
8.8 OChem
8.8.1 OChem Comapny Information
8.8.2 OChem Business Overview
8.8.3 OChem Amikacin Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 OChem Amikacin Product Portfolio
8.8.5 OChem Recent Developments
8.9 MuseChem
8.9.1 MuseChem Comapny Information
8.9.2 MuseChem Business Overview
8.9.3 MuseChem Amikacin Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 MuseChem Amikacin Product Portfolio
8.9.5 MuseChem Recent Developments
8.10 Mucule
8.10.1 Mucule Comapny Information
8.10.2 Mucule Business Overview
8.10.3 Mucule Amikacin Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Mucule Amikacin Product Portfolio
8.10.5 Mucule Recent Developments
8.11 Inter Bio Screen
8.11.1 Inter Bio Screen Comapny Information
8.11.2 Inter Bio Screen Business Overview
8.11.3 Inter Bio Screen Amikacin Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Inter Bio Screen Amikacin Product Portfolio
8.11.5 Inter Bio Screen Recent Developments
8.12 Clearsynth
8.12.1 Clearsynth Comapny Information
8.12.2 Clearsynth Business Overview
8.12.3 Clearsynth Amikacin Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Clearsynth Amikacin Product Portfolio
8.12.5 Clearsynth Recent Developments
8.13 Biosynth
8.13.1 Biosynth Comapny Information
8.13.2 Biosynth Business Overview
8.13.3 Biosynth Amikacin Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Biosynth Amikacin Product Portfolio
8.13.5 Biosynth Recent Developments
8.14 Angene
8.14.1 Angene Comapny Information
8.14.2 Angene Business Overview
8.14.3 Angene Amikacin Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Angene Amikacin Product Portfolio
8.14.5 Angene Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Amikacin Value Chain Analysis
9.1.1 Amikacin Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Amikacin Production Mode & Process
9.2 Amikacin Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Amikacin Distributors
9.2.3 Amikacin Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.